Literature DB >> 33452394

Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease.

Shogo Matsuda1, Takuya Kotani2, Takayasu Suzuka1, Takao Kiboshi1, Keisuke Fukui3, Minako Wakama1, Takaaki Ishida1, Youhei Fujiki1, Hideyuki Shiba1, Koji Nagai1, Kenichiro Hata1, Takeshi Shoda4, Yuri Ito3, Shigeki Makino1, Tohru Takeuchi1.   

Abstract

The prognosis of microscopic polyangiitis (MPA) with interstitial lung disease (ILD) is significantly worse than that of MPA without ILD. However, the clinical characteristics in MPA-ILD, especially poor prognostic factors, are not elucidated. We evaluated demographic, clinical, laboratory, and radiological findings, treatments, and outcomes of 80 patients with MPA, and investigated prognostic factors of respiratory-related death in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA) positive MPA-ILD. Ground-glass opacity and fibrosis were evaluated as scores on high-resolution computed tomography (HRCT). The presence of ILD was consistent with a high risk of respiratory-related death (hazard ratio, 4.8; P = 0.04). Multivariable logistic regression analyses using propensity scoring showed right or left lower lobe fibrosis score to be significantly associated with respiratory-related death (P = 0.0005 and 0.0045, respectively). A right or left lower lobe fibrosis score ≥ 2, indicating the presence of honeycombing at 1 cm above the diaphragm, was determined to be the best cut-off value indicating a poor prognosis. The 5-year survival rate was significantly lower in patients with right or left lower lobe fibrosis score ≥ 2 (survival rates: 37% and 19%, respectively) than those with a score < 2 (71% and 68%, respectively) (P = 0.002 and 0.0007, respectively). These findings suggest that the presence of honeycomb lesions in bilateral lower lobes on chest HRCT was associated with respiratory-related death in patients with MPO-ANCA positive MPA-ILD.

Entities:  

Year:  2021        PMID: 33452394      PMCID: PMC7810976          DOI: 10.1038/s41598-021-81311-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  28 in total

1.  Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients.

Authors:  Yumiko Ando; Fumito Okada; Shunro Matsumoto; Hiromu Mori
Journal:  J Comput Assist Tomogr       Date:  2004 Sep-Oct       Impact factor: 1.826

2.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

3.  Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital-Based Japanese Patients.

Authors:  Mieko Yamagata; Kei Ikeda; Kenji Tsushima; Ken Iesato; Mitsuhiro Abe; Takashi Ito; Daisuke Kashiwakuma; Shin-Ichiro Kagami; Itsuo Iwamoto; Daiki Nakagomi; Takao Sugiyama; Yuichiro Maruyama; Shunsuke Furuta; David Jayne; Takashi Uno; Koichiro Tatsumi; Hiroshi Nakajima
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

4.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

5.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

6.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

Review 7.  Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature.

Authors:  B Hervier; C Pagnoux; C Agard; J Haroche; Z Amoura; L Guillevin; M A Hamidou
Journal:  Ann Rheum Dis       Date:  2008-10-28       Impact factor: 19.103

8.  Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.

Authors:  G E Tzelepis; M Kokosi; A Tzioufas; S P Toya; K A Boki; A Zormpala; H M Moutsopoulos
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

9.  Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.

Authors:  Rose A Devasia; Amondrea Blackman; Tebeb Gebretsadik; Marie Griffin; Ayumi Shintani; Carolyn May; Teresa Smith; Nancy Hooper; Fernanda Maruri; Jon Warkentin; Ed Mitchel; Timothy R Sterling
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

10.  Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study.

Authors:  Shoichi Ozaki; Tatsuya Atsumi; Taichi Hayashi; Akihiro Ishizu; Shigeto Kobayashi; Shunichi Kumagai; Yasuyuki Kurihara; Manae S Kurokawa; Hirofumi Makino; Hiroko Nagafuchi; Kimimasa Nakabayashi; Norihiro Nishimoto; Machi Suka; Yasuhiko Tomino; Hidehiro Yamada; Kunihiro Yamagata; Masaharu Yoshida; Wako Yumura; K Amano; Y Arimura; K Hatta; S Ito; H Kikuchi; E Muso; H Nakashima; Y Ohsone; Y Suzuki; H Hashimoto; A Koyama; S Matsuo; H Kato
Journal:  Mod Rheumatol       Date:  2011-09-18       Impact factor: 3.023

View more
  2 in total

1.  Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.

Authors:  Koichi Yamaguchi; Aya Yamaguchi; Miki Itai; Yuji Onuki; Yuki Shin; Shogo Uno; Chiharu Hanazato; Kohei Taguchi; Kazue Umetsu; Masaki Aikawa; Shunichi Kouno; Masao Takemura; Kenichiro Hara; Shinsuke Motegi; Mayuko Tsukida; Fumie Ota; Yoshito Tsukada; Mitsuru Motegi; Masao Nakasatomi; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Keiju Hiromura; Toshitaka Maeno
Journal:  Rheumatol Int       Date:  2021-05-30       Impact factor: 2.631

Review 2.  Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.

Authors:  Hideaki Yamakawa; Yuko Toyoda; Tomohisa Baba; Tomoo Kishaba; Taiki Fukuda; Tamiko Takemura; Kazuyoshi Kuwano
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.